Researchers at Moffitt Cancer Center have reported encouraging results from a phase 1B clinical trial showing that the immunotherapy drug avelumab, when combined with whole brain radiotherapy, may provide a safe and effective…
Early trial finds promise for avelumab and radiation in treating leptomeningeal disease
